| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2014 | US8691827 Amino tetrahydro-pyridopyrimidine PDE10 inhibitors |
| 04/08/2014 | US8691826 Compounds |
| 04/08/2014 | US8691825 Inhibitors of AKT activity |
| 04/08/2014 | US8691824 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 04/08/2014 | US8691823 Prodrugs of (4aS, 13ar)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-9-11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1H-pyrido[1,2-a]pyrrolo[1′,2′:3:4]imidazo[1,2-d]pyrazine-8-carboxamide and their use in the treatment of HIV infection |
| 04/08/2014 | US8691822 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 04/08/2014 | US8691821 Oxazolidinones as modulators of mGluR5 |
| 04/08/2014 | US8691820 CDK inhibitors |
| 04/08/2014 | US8691819 Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions |
| 04/08/2014 | US8691818 Cyclic triazo and diazo sodium channel blockers |
| 04/08/2014 | US8691817 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof |
| 04/08/2014 | US8691815 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 04/08/2014 | US8691814 Deazapurines and uses thereof |
| 04/08/2014 | US8691813 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| 04/08/2014 | US8691811 Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 04/08/2014 | US8691810 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
| 04/08/2014 | US8691809 Substituted benzoazepines as toll-like receptor modulators |
| 04/08/2014 | US8691808 Antiviral compounds and their methods of use |
| 04/08/2014 | US8691807 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors |
| 04/08/2014 | US8691806 Pyrazole derivatives as protein kinase modulators |
| 04/08/2014 | US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 04/08/2014 | US8691803 Process for the preparation of antibiotic compounds |
| 04/08/2014 | US8691802 Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
| 04/08/2014 | US8691801 Use of manzamine compounds in anti-cancer therapeutic regimens |
| 04/08/2014 | US8691800 Quinoline derivatives as antibacterial agents |
| 04/08/2014 | US8691799 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 04/08/2014 | US8691796 Pharmaceutical composition and method for inhibiting inflammation |
| 04/08/2014 | US8691795 Process for producing sugar chain derivative, structure analysis method, and sugar chain derivative |
| 04/08/2014 | US8691794 Topical composition for skin containing polysaccharide extract of red ginseng |
| 04/08/2014 | US8691793 Modified macromolecules and associated methods of synthesis and use |
| 04/08/2014 | US8691792 Methods and compositions for improving gastrointetinal health |
| 04/08/2014 | US8691791 Microspheres for treatment of brain tumors |
| 04/08/2014 | US8691789 Probe of iodine-123 marker thymidine (FLT)analogue [123I]-IaraU |
| 04/08/2014 | US8691788 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 04/08/2014 | US8691787 Nucleotide and oligonucleotide prodrugs |
| 04/08/2014 | US8691785 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 04/08/2014 | US8691784 MCP-1 binding nucleic acids |
| 04/08/2014 | US8691780 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 04/08/2014 | US8691779 Compositions including triciribine and taxanes and methods of use thereof |
| 04/08/2014 | US8691778 Flurbiprofen and muscle relaxant gel combinations thereof |
| 04/08/2014 | US8691777 Combination therapy |
| 04/08/2014 | US8691776 Synthesis of high molecular weight iron-saccharidic complexes |
| 04/08/2014 | US8691775 Use of drugs that activate P2Y receptors to enhance synaptogenesis |
| 04/08/2014 | US8691747 Method of treatment based on ATAD2 inhibitors |
| 04/08/2014 | US8691573 Stem cell cultures |
| 04/08/2014 | US8691571 Extending tissue preservation |
| 04/08/2014 | US8691556 Methods and compositions for vein harvest and autografting |
| 04/08/2014 | US8691546 Inhibitors of Bruton's tyrosine kinase |
| 04/08/2014 | US8691511 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays |
| 04/08/2014 | US8691289 Methods of treating outer eye disorders using high ORP acid water and compositions thereof |
| 04/08/2014 | US8691286 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes |
| 04/08/2014 | US8691283 Standardized bee venom preparation |
| 04/08/2014 | US8691281 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (C)chromen-3-yl sulfamate and polymorphs thereof |
| 04/08/2014 | US8691277 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
| 04/08/2014 | US8691275 Controlled-release melatonin compositions and related methods |
| 04/08/2014 | US8691267 Adhesive patch |
| 04/08/2014 | US8691255 Method of producing high alcohol content foaming compositions with silicone-based surfactants |
| 04/08/2014 | US8691252 Storage-stable, anti-microbial compositions including ceragenin compounds and methods of use |
| 04/08/2014 | US8691247 Skin rejuvenation cream |
| 04/08/2014 | US8691246 Composition for forming a temporary intestinal occlusion in a mammal |
| 04/08/2014 | US8691245 Composition for forming a temporary obstruction and method of forming the same |
| 04/08/2014 | US8691235 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions |
| 04/08/2014 | US8691216 Methods of using regenerative cells to promote wound healing |
| 04/08/2014 | US8691213 Protein free formula |
| 04/08/2014 | US8691209 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 04/08/2014 | US8691205 Mono- and di-PEG IL-10 production; and uses |
| 04/08/2014 | US8691204 Synthetic diblock copolypeptide hydrogels for use in the central nervous system |
| 04/08/2014 | US8691203 Method comprising contacting tissue with a cross-linkable polyester prepolymer |
| 04/08/2014 | US8691202 Skin compositions and methods of use thereof |
| 04/08/2014 | US8691201 Deodorant material |
| 04/08/2014 | US8691197 In-shower lotion compositions comprising up to 10% free fatty acids wherein ratio of unsaturated to saturated fatty acids is at least 1:1 |
| 04/08/2014 | US8691185 Benzothiazole derivative compounds, compositions and uses |
| 04/08/2014 | US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same |
| 04/08/2014 | CA2820479A1 Patch and method for producing the same |
| 04/08/2014 | CA2816033C Cathepsin s inhibitor compounds |
| 04/08/2014 | CA2806604C Synthetic heparin pentasaccharides |
| 04/08/2014 | CA2782469C Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same |
| 04/08/2014 | CA2780040C 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 04/08/2014 | CA2771885C 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands |
| 04/08/2014 | CA2746795C Method for crystallizing reduced coenzyme q10 |
| 04/08/2014 | CA2742703C Novel 4- (heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
| 04/08/2014 | CA2723132C Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 04/08/2014 | CA2685208C Methods and compositions of inhibiting complement and cellular activation with dextran sulfate |
| 04/08/2014 | CA2673483C Compositions of chk1 inhibitors |
| 04/08/2014 | CA2664548C Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation |
| 04/08/2014 | CA2653827C Novel blonanserin tape preparation |
| 04/08/2014 | CA2653772C 9,10-secopregnane derivative and pharmaceutical |
| 04/08/2014 | CA2641933C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 04/08/2014 | CA2641776C Pyrazoloquinolones are potent parp inhibitors |
| 04/08/2014 | CA2641575C Stabilization of solid thyroid drug formulations |
| 04/08/2014 | CA2634553C Triazole derivatives |
| 04/08/2014 | CA2630271C Fused bicyclic mtor inhibitors |
| 04/08/2014 | CA2629046C Abuse resistant transmucosal drug delivery device |
| 04/08/2014 | CA2627223C Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 04/08/2014 | CA2626449C Heterocyclic compounds and their use |
| 04/08/2014 | CA2624568C Oligouronate treatment |
| 04/08/2014 | CA2623848C Topical anesthetic for dental procedures |
| 04/08/2014 | CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 04/08/2014 | CA2615533C Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic |
| 04/08/2014 | CA2605773C Stable emulsion composition |